IL17A and skin disorder: Loaded into a well-developed topical delivery system, LA restored the skin barrier function and improved the therapeutic effect by inhibiting the IL-17/IL-23 axis cytokines protein which may also regulate autophagy-related protein expression in the IMQ-induced psoriasis-like dermatitis in mice.